Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| 1 |
Apple
AAPL
|
$29.1B |
| 2 |
Tesla
TSLA
|
$4.68B |
| 3 |
Alibaba
BABA
|
$2.51B |
| 4 |
United Parcel Service
UPS
|
$932M |
| 5 |
Danaher
DHR
|
$785M |
Top Sells
| 1 |
Shopify
SHOP
|
$1.4B |
| 2 |
Adobe
ADBE
|
$1.23B |
| 3 |
Visa
V
|
$1.2B |
| 4 |
NVIDIA
NVDA
|
$1.01B |
| 5 |
Salesforce
CRM
|
$1B |
Sector Composition
| 1 | Technology | 27.4% |
| 2 | Healthcare | 15.49% |
| 3 | Consumer Discretionary | 14.54% |
| 4 | Financials | 10.42% |
| 5 | Communication Services | 10.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
iShares Core MSCI Emerging Markets ETF
IEMG
$101B
| $901M | 0.09% |
17,056,390
+1,620,570
| +10% | +$85.6M |
|
202
Southern Company
SO
$102B
| $900M | 0.09% |
16,595,409
+2,216,945
| +15% | +$120M |
|
203
Amdocs
DOX
$9.32B
| $899M | 0.09% |
15,656,363
+133,824
| +0.9% | +$7.68M |
|
204
Vanguard Growth ETF
VUG
$182B
| $896M | 0.09% |
3,935,949
-209,514
| -5% | -$47.7M |
|
205
Sarepta Therapeutics
SRPT
$1.79B
| $891M | 0.09% |
6,343,696
-1,481,158
| -19% | -$208M |
|
206
ON Semiconductor
ON
$19.5B
| $876M | 0.09% |
40,409,236
+10,345,977
| +34% | +$224M |
|
207
Nice
NICE
$8.45B
| $875M | 0.09% |
3,855,848
+855,490
| +29% | +$194M |
|
208
Edwards Lifesciences
EW
$48B
| $871M | 0.09% |
10,909,202
-1,456,930
| -12% | -$116M |
|
209
Sysco
SYY
$38.5B
| $871M | 0.09% |
13,992,669
-1,149,446
| -8% | -$71.5M |
|
210
Citigroup
C
$173B
| $858M | 0.09% |
19,897,452
-13,282,593
| -40% | -$573M |
|
211
Morgan Stanley
MS
$236B
| $849M | 0.09% |
17,563,623
+889,332
| +5% | +$43M |
|
212
Neurocrine Biosciences
NBIX
$14B
| $837M | 0.08% |
8,703,746
+337,012
| +4% | +$32.4M |
|
|
NBIS
213
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.5B
| $834M | 0.08% |
12,781,993
+1,514,358
| +13% | +$98.8M |
|
214
Vanguard FTSE Developed Markets ETF
VEA
$168B
| $825M | 0.08% |
20,173,767
+58,476
| +0.3% | +$2.39M |
|
215
Whirlpool
WHR
$5.05B
| $821M | 0.08% |
4,466,487
-386,320
| -8% | -$71M |
|
216
Ascendis Pharma
ASND
$12.2B
| $816M | 0.08% |
5,284,499
+485,916
| +10% | +$75M |
|
217
Acadia Pharmaceuticals
ACAD
$4.39B
| $815M | 0.08% |
19,748,348
-1,041,956
| -5% | -$43M |
|
218
Chubb
CB
$110B
| $810M | 0.08% |
6,978,011
-289,737
| -4% | -$33.6M |
|
219
ResMed
RMD
$39.7B
| $805M | 0.08% |
4,696,482
-716,721
| -13% | -$123M |
|
220
Trane Technologies
TT
$91.5B
| $793M | 0.08% |
6,538,308
+1,348,948
| +26% | +$164M |
|
221
SAP
SAP
$309B
| $789M | 0.08% |
5,060,697
-87,581
| -2% | -$13.6M |
|
222
Equity Lifestyle Properties
ELS
$11.6B
| $785M | 0.08% |
12,801,972
+445,926
| +4% | +$27.3M |
|
223
Jabil
JBL
$21.5B
| $774M | 0.08% |
22,585,846
-20,585
| -0.1% | -$705K |
|
224
GoDaddy
GDDY
$20.1B
| $766M | 0.08% |
10,082,824
-2,550,436
| -20% | -$194M |
|
225
Freeport-McMoran
FCX
$63.7B
| $764M | 0.08% |
48,860,839
+39,742,307
| +436% | +$622M |
|